Atrial Fibrillation Screening According to Genetic Risk
JACC · 2026
DOI: 10.1016/j.jacc.2025.09.024 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JACC, 2026. Verfasst von Oliver B Vad und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, the Heart Centre, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark; Department of Biomedical Sciences, Un…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Stroke, Electrocardiography, Ambulatory, Mass Screening. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Hjerteforeningen, Horizon 2020, Aalborg University.
Abstract (Originalsprache)
BACKGROUND: Polygenic risk scores (PRS) hold promise in risk stratification and screening for cardiovascular diseases, including atrial fibrillation (AF). OBJECTIVES: This study investigated the efficacy of AF screening for stroke prevention based on a PRS for AF. METHODS: This prespecified post hoc analysis of the randomized LOOP (Atrial Fibrillation Detected by Continuous ECG Monitoring Using Implantable Loop Recorder to Prevent Stroke in High-Risk Individuals) study included 5,656 AF-naive individuals aged ≥70 years with stroke risk factors and available genetic data. The participants were randomized 1:3 for screening with an implantable loop recorder (ILR) vs usual care. Genetic risk of AF was assessed using a PRS for AF (PRSAF). The primary outcome was a composite of stroke and systemic embolism (SE). Interaction between the randomization arm and PRSAF was assessed in cause-specific Cox regressions for the full cohort and across the observed range of polygenic risk using a continuous prediction grid. Secondary analyses included models stratified by PRS level, gene-screening interactions for major bleeding events, and associations between PRSAF and AF burden (≥1 episode lasting ≥24 hours among participants with ILR-detected AF). RESULTS: Over a median follow-up period of 5.4 years, 969 participants (17.1%) received a diagnosis of AF, 296 (5.2%) had stroke/SE, and 206 (3.6%) had major bleeding. PRSAF was associated with higher rates of AF (HR per SD increase: 1.20; 95% CI: 1.13-1.28; P < 0.001). A significant interaction was observed between ILR screening and PRSAF for stroke/SE (Pinteraction = 0.006). ILR screening was associated with lower rates of stroke/SE in individuals with PRSAF ≥median (HR: 0.65; 95% CI: 0.43-0.97; P = 0.036) but not in those with PRSAF
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, the Heart Centre, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Cardiology, the Heart Centre, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark. Electronic address: soeren.zoega.diederichsen@regionh.dk.
- Department of Cardiology, the Heart Centre, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
- Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Cardiology, Zealand University Hospital Roskilde, Roskilde, Denmark.
- Department of Health Science and Technology, Aalborg University, Gistrup, Denmark.
Förderung
- Hjerteforeningen
- Horizon 2020
- Aalborg University
- Arvid Nilsson Foundation
- Capital Region of Denmark
- Skibsreder Per Henriksen R og Hustrus Fond
- Innovation Fund Denmark
- Odense Universitetshospital
Zitieren
APA
Vad, O. B., Diederichsen, S. Z., Xing, L. Y., Paludan-Müller, C., Monfort, L. M., Ahlberg, G., Andreasen, L., Haugan, K. J., Graff, C., Højberg, S., Krieger, D., Brandes, A., Køber, L., & Svendsen, J. H. (2026). Atrial Fibrillation Screening According to Genetic Risk. JACC. https://doi.org/10.1016/j.jacc.2025.09.024
Vancouver
Vad OB, Diederichsen SZ, Xing LY, Paludan-Müller C, Monfort LM, Ahlberg G, et al. Atrial Fibrillation Screening According to Genetic Risk. JACC. 2026. doi:10.1016/j.jacc.2025.09.024
BibTeX
@article{Vad2026,
author = {Vad, Oliver B and Diederichsen, Søren Z and Xing, Lucas Y and Paludan-Müller, Christian and Monfort, Laia M and Ahlberg, Gustav and Andreasen, Laura and Haugan, Ketil J and Graff, Claus and Højberg, Søren and Krieger, Derk and Brandes, Axel and Køber, Lars and Svendsen, Jesper H},
title = {Atrial Fibrillation Screening According to Genetic Risk},
journal = {JACC},
year = {2026},
doi = {10.1016/j.jacc.2025.09.024}
}
EUVIMED